HIV and Liver Disease 2016

HIV and Liver Disease 2016 is organized by University of Cincinnati and would be held during Sep 15 - 17, 2016 at Jackson Lake Lodge, Moran, Wyoming, United States of America.

The targeted audience for this medical event basically for experts in the fields of Infectious Diseases and Hepatology and Liver Transplantation, students, trainees, young investigators, nurse practitioners and other clinicians, and those involved with drug development and approval.

Educational Objectives :

After completing this activity, the participant should be better able to:

- Review the epidemiology of HIV infection and liver disease in co-infected patients
- Discuss current treatment guidelines for the management of HIV-infected patients with HBV and HCV
- Recognize Hepatic fibrosis in HIV
- Explain the pathogenesis of liver injury and disease progression in patients infected with HIV
- Describe the mutation and evolution of HBV and HCV infection in patients with HIV
- Report on the drugs being developed for the treatment of HCV-infected patients
- Analyze the progression of decompensated liver disease in patients with HIV infection
- Assess the risk of antiretroviral therapy (ART) injury in patients with ESLD
- Summarize the psychiatric difficulties that can develop in HIV-infected patients with liver disease
- Examine treatment outcomes in injection drug users co-infected with HIV and liver disease